Westminster, CO, United States of America

Josef Oleksyszyn

This inventor holds 2 USPTO granted patents. Top assignee: Georgia Tech Research Corporation. Active years: 1992-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josef Oleksyszyn. Retrieved from https://idiyas.com/inventor/josef-oleksyszyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1992-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Josef Oleksyszyn

Introduction

Josef Oleksyszyn is a notable inventor based in Westminster, CO (US). He has made significant contributions to the field of biochemistry, particularly in the development of serine protease inhibitors. With a total of 2 patents, his work has implications for anti-inflammatory treatments.

Latest Patents

Oleksyszyn's latest patents include "Substituted isocoumarins as serine protease inhibitors" and "Substituted isocoumarins, their use in inhibiting serine proteases with trypsin-like, chymotrypsin-like and elastase-like specificity and their roles as anti-inflammatory agents." These innovations focus on the therapeutic potential of substituted isocoumarins in medical applications.

Career Highlights

He is currently associated with the Georgia Tech Research Corporation, where he continues to advance his research. His work is characterized by a commitment to exploring new avenues in the field of protease inhibition.

Collaborations

Some of his notable coworkers include James C Powers and Chih-Min Kam, who contribute to the collaborative environment that fosters innovation.

Conclusion

Josef Oleksyszyn's contributions to the field of biochemistry through his patents and research at Georgia Tech Research Corporation highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…